FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 315:1377-1381 November 27, 1986 Number 22 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We randomly assigned 230 patients with resected Stage II or III epidermoid (squamous-cell) lung cancer to receive postoperative adjuvant radiotherapy or no adjuvant treatment. Careful intraoperative staging had been performed in all patients. Before randomization, patients were stratified according to stage, weight loss, age, and institution. Prognostic variables, such as stage, weight loss, age, nodal-disease status, and tumor status, were equally distributed between the two groups. The mean time from randomization to analysis was 3.5 years among the 210 eligible patients. There was no evidence that radiotherapy improved survival, and although recurrence rates appeared to be somewhat reduced among patients assigned to radiotherapy, these decreases were not statistically significant. However, radiotherapy did produce a striking and significant reduction in recurrences to the ipsilateral lung and mediastinum. Moreover, overall recurrence rates were reduced by radiotherapy in patients with N2 disease (P less than 0.05), although even this subgroup had no evidence of improved survival. We conclude that radiotherapy can reduce local recurrences after resection of epidermoid carcinoma of the lung, but that it does not increase survival rates.

This article has been cited by other articles:

• Matsuguma, H., Nakahara, R., Ishikawa, Y., Suzuki, H., Inoue, K., Katano, S., Yokoi, K. (2008). Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved. ICVTS 7: 573-577 [Abstract] [Full Text]  
• Robinson, L. A., Ruckdeschel, J. C., Wagner, H. Jr, Stevens, C. W. (2007). Treatment of Non-small Cell Lung Cancer-Stage IIIA: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition). Chest 132: 243S-265S [Abstract] [Full Text]  
• Lally, B. E., Zelterman, D., Colasanto, J. M., Haffty, B. G., Detterbeck, F. C., Wilson, L. D. (2006). Postoperative Radiotherapy for Stage II or III Non-Small-Cell Lung Cancer Using the Surveillance, Epidemiology, and End Results Database. JCO 24: 2998-3006 [Abstract] [Full Text]  
• Bernstein, E. D., Herbert, S. M., Hanna, N. H. (2006). Chemotherapy and Radiotherapy in the Treatment of Resectable Non-Small-Cell Lung Cancer. Ann. Surg. Oncol. 13: 291-301 [Abstract] [Full Text]  
• Martin, L. W., Correa, A. M., Hofstetter, W., Hong, W. K., Komaki, R., Putnam, J. B. Jr, Rice, D. C., Smythe, W. R., Swisher, S. G., Vaporciyan, A. A., Walsh, G. L., Roth, J. A. (2005). The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution. J. Thorac. Cardiovasc. Surg. 130: 1601-1610 [Abstract] [Full Text]  
• Visbal, A. L., Leighl, N. B., Feld, R., Shepherd, F. A. (2005). Adjuvant Chemotherapy for Early-Stage Non-small Cell Lung Cancer. Chest 128: 2933-2943 [Abstract] [Full Text]  
• Lemaire, A., Burfeind, W. R., Toloza, E., Balderson, S., Petersen, R. P., Harpole, D. H. Jr, D'Amico, T. A. (2005). Outcomes of Tracheobronchial Stents in Patients With Malignant Airway Disease. Ann. Thorac. Surg. 80: 434-438 [Abstract] [Full Text]  
• Bogart, J. A., Aronowitz, J. N. (2005). Localized Non-Small Cell Lung Cancer: Adjuvant Radiotherapy in the Era of Effective Systemic Therapy. Clin. Cancer Res. 11: 5004s-5010s [Abstract] [Full Text]  
• Bradley, J. D., Paulus, R., Graham, M. V., Ettinger, D. S., Johnstone, D. W., Pilepich, M. V., Machtay, M., Komaki, R., Atkins, J., Curran, W. J. (2005). Phase II Trial of Postoperative Adjuvant Paclitaxel/Carboplatin and Thoracic Radiotherapy in Resected Stage II and IIIA Non-Small-Cell Lung Cancer: Promising Long-Term Results of the Radiation Therapy Oncology Group--RTOG 9705. JCO 23: 3480-3487 [Abstract] [Full Text]  
• Pisters, K. M.W., Le Chevalier, T. (2005). Adjuvant Chemotherapy in Completely Resected Non-Small-Cell Lung Cancer. JCO 23: 3270-3278 [Abstract] [Full Text]  
• Spira, A., Ettinger, D. S. (2004). Multidisciplinary Management of Lung Cancer. NEJM 350: 379-392 [Full Text]  
• Fernando, H. C., Sasatomi, E., Christie, N. A., Buenaventura, P. O., Finkelstein, S. D., Yousem, S. A., Soose, R., Close, J. M., Luketich, J. D. (2004). Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: A pilot study. J. Thorac. Cardiovasc. Surg. 127: 87-91 [Abstract] [Full Text]  
• Price, A (2003). Lung cancer * 5: State of the art radiotherapy for lung cancer. Thorax 58: 447-452 [Abstract] [Full Text]  
• Scott, W. J., Howington, J., Movsas, B. (2003). Treatment of Stage II Non-small Cell Lung Cancer. Chest 123: 188S-201S [Abstract] [Full Text]  
• Choi, Y. S., Shim, Y. M., Kim, J., Kim, K. (2002). Recurrence-free survival and prognostic factors in resected pN2 non-small cell lung cancer. Eur. J. Cardiothorac. Surg. 22: 695-700 [Abstract] [Full Text]  
• Vallieres, E., Machtay, M., Glatstein, E., Bonner, J. A. (2002). Adjuvant Radiation Therapy After Complete Resection of Non-Small-Cell Lung Cancer. JCO 20: 1427-1429 [Full Text]  
• Deslauriers, J. (2002). Current surgical treatment of nonsmall cell lung cancer 2001. Eur Respir J 19: 61S-70s [Abstract] [Full Text]  
• Machtay, M., Lee, J. H., Shrager, J. B., Kaiser, L. R., Glatstein, E. (2001). Risk of Death From Intercurrent Disease Is Not Excessively Increased by Modern Postoperative Radiotherapy for High-Risk Resected Non-Small-Cell Lung Carcinoma. JCO 19: 3912-3917 [Abstract] [Full Text]  
• Grannis, F. W. Jr (2001). A response to ""Clinical Trials in Lung Cancer: Truth, Justice, and the American Way"". Ann. Thorac. Surg. 72: 1438-1438 [Full Text]  
• Chien, C.-R., Chen, S.-W., Hsieh, C.-Y., Liang, J.-A., Yang, S.-N., Huang, C.-Y., Lin, F.-J. (2001). Intra-thoracic Failure Pattern and Survival Status Following 3D Conformal Radiotherapy for Non-small Cell Lung Cancer: a Preliminary Report. Jpn J Clin Oncol 31: 55-60 [Abstract] [Full Text]  
• Gunen, H., Kizkin, O., Tahaoglu, C., Aktas, O. (2001). Utility of Blind Forceps Biopsy of the Main Carina and Upper-Lobe Carina in Patients With Non-small Cell Lung Cancer. Chest 119: 632-637 [Abstract] [Full Text]  
• Keller, S. M., Adak, S., Wagner, H., Herskovic, A., Komaki, R., Brooks, B. J., Perry, M. C., Livingston, R. B., Johnson, D. H., The Eastern Cooperative Oncology Group, (2000). A Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II or IIIa Non-Small-Cell Lung Cancer. NEJM 343: 1217-1222 [Abstract] [Full Text]  
• Wagner, H. Jr (2000). Postoperative Adjuvant Therapy for Patients With Resected Non-Small Cell Lung Cancer: Still Controversial After all These Years. Chest 117: 110S-118S [Abstract] [Full Text]  
• Bunn, P. A. Jr, Mault, J., Kelly, K. (2000). Adjuvant and Neoadjuvant Chemotherapy for Non-Small Cell Lung Cancer : A Time for Reassessment?. Chest 117: 119S-122S [Abstract] [Full Text]  
• Lee, J. H., Machtay, M., Kaiser, L. R., Friedberg, J. S., Hahn, S. M., McKenna, M. G., McKenna, W. G. (1999). Non-Small Cell Lung Cancer: Prognostic Factors in Patients Treated with Surgery and Postoperative Radiation Therapy. Radiology 213: 845-852 [Abstract] [Full Text]  
• Park, J. H., Shim, Y. M., Baek, H. J., Kim, M.-S., Choe, D. H., Cho, K.-J., Lee, C.-T., Zo, J. I. (1999). Postoperative adjuvant therapy for stage II non-small-cell lung cancer. Ann. Thorac. Surg. 68: 1821-1826 [Abstract] [Full Text]  
• Yoshino, I., Nakanishi, R., Osaki, T., Takenoyama, M., Taga, S., Hanagiri, T., Yasumoto, K. (1999). Unfavorable Prognosis of Patients With Stage II Non-small Cell Lung Cancer Associated With Macroscopic Nodal Metastases. Chest 116: 144-149 [Abstract] [Full Text]  
• George, S., Schell, M. J., Detterbeck, F. C., Socinski, M. A. (1998). Adjuvant Chemotherapy for Resected Non-Small Cell Carcinoma of the Lung: Why We Still Don't Know. The Oncologist 3: 35-44 [Abstract] [Full Text]  
• Nakanishi, R., Osaki, T., Nakanishi, K., Yoshino, I., Yoshimatsu, T., Watanabe, H., Nakata, H., Yasumoto, K. (1997). Treatment Strategy for Patients With Surgically Discovered N2 Stage IIIA Non-Small Cell Lung Cancer. Ann. Thorac. Surg. 64: 342-348 [Abstract] [Full Text]  
• Mizushima, Y., Noto, H., Sugiyama, S., Kusajima, Y., Yamashita, R., Kashii, T., Kobayashi, M. (1997). Survival and Prognosis After Pneumonectomy for Lung Cancer in the Elderly. Ann. Thorac. Surg. 64: 193-198 [Abstract] [Full Text]  
• Olak, J., Ng, A. (1996). Diagnosis and Treatment of Early-Stage Non-Small Cell Lung Cancer. The Oncologist 1: 201-209 [Abstract] [Full Text]  
• Sugarbaker, D. J., Herndon, J., Kohman, L. J., Krasna, M. J., Green, M. R., Group, t. C. a. L. G. B T. S., Rusch, S. b. V. (1995). Results of cancer and leukemia group B protocol 8935A multiinstitutional phase II trimodality trial for stage IIIa (N2) non-small-cell lung cancer. J. Thorac. Cardiovasc. Surg. 109: 473-485 [Abstract] [Full Text]  
• Yano, T., Hara, N., Ichinose, Y., Asoh, H., Yokoyama, H., Ohta, M., Hata, K. (1994). Local recurrence after complete resection for non-small-cell carcinoma of the lung: Significance of local control by radiation treatment. J. Thorac. Cardiovasc. Surg. 107: 8-12 [Abstract] [Full Text]